24.92

1.46% -0.37

After Hours: 24.85 -0.07 -0.28%

Baxter International Inc (BAX)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

Baxter International Inc stock is traded at $24.92, with a volume of 5.49M. It is down -1.46% in the last 24 hours and up +6.63% over the past month. Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.

Previous Close:

$25.29

Open:

$25.2

24h Volume:

5.49M

Relative Volume:

0.97

Market Cap:

$12.88B

Revenue:

$11.32B

Net Income/Loss:

$-981.00M

P/E Ratio:

-12.76

EPS:

-1.9532

Net Cash Flow:

$714.00M

1W Performance:

+1.67%

1M Performance:

+6.63%

6M Performance:

+34.78%

1Y Performance:

+7.55%

1-Day Range:

$24.81

$25.25

1-Week Range:

$24.68

$25.71

52-Week Range:

$15.73

$30.00

Baxter International Inc Stock (BAX) Company Profile

Name

Baxter International Inc

Sector

Healthcare (1053)

Industry

Medical Instruments & Supplies (51)

Phone

(224) 948-2000

Address

ONE BAXTER PARKWAY, DEERFIELD, IL

Employee

37,500

Twitter

@baxter_intl

Next Earnings Date

2026-10-29

Latest SEC Filings

BAX's Discussions on Twitter

Compare BAX vs ISRG, BDX, RMD, ALC, MDLN

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BAX Baxter International Inc	24.92	12.88B	11.32B	-981.00M	714.00M	-1.9532
ISRG Intuitive Surgical Inc	445.88	157.52B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	195.03	53.12B	21.37B	1.41B	3.07B	3.9437
RMD Resmed Inc	250.80	35.27B	5.54B	1.52B	1.74B	10.37
ALC Alcon Inc	69.42	33.56B	10.63B	819.00M	1.59B	1.6577
MDLN Medline Inc	32.38	28.41B	29.14B	1.07B	1.05B	1.1956

Baxter International Inc Stock (BAX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-20-26	Initiated	Wolfe Research	Peer Perform
Oct-07-26	Initiated	Barclays	Underweight
Jul-31-26	Upgrade	Citigroup	Sell → Neutral
May-28-26	Downgrade	Citigroup	Neutral → Sell
Oct-31-25	Downgrade	Argus	Buy → Hold
Aug-04-25	Downgrade	Stifel	Buy → Hold
Aug-01-25	Downgrade	Goldman	Buy → Neutral
Feb-26-25	Resumed	Goldman	Buy
Feb-24-25	Upgrade	Argus	Hold → Buy
Feb-20-25	Resumed	Barclays	Overweight
Jul-15-24	Downgrade	Morgan Stanley	Equal-Weight → Underweight
May-30-24	Initiated	Goldman	Neutral
May-10-24	Downgrade	TD Cowen	Buy → Hold
May-30-23	Resumed	Morgan Stanley	Equal-Weight
Mar-29-23	Initiated	UBS	Neutral
Jan-06-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-05-23	Downgrade	Raymond James	Outperform → Mkt Perform
Jan-03-23	Downgrade	BofA Securities	Buy → Neutral
Dec-19-22	Downgrade	JP Morgan	Overweight → Neutral
Dec-15-22	Downgrade	Deutsche Bank	Buy → Hold
Dec-12-22	Downgrade	Citigroup	Buy → Neutral
Oct-18-22	Initiated	Barclays	Overweight
Oct-12-22	Initiated	Jefferies	Hold
Jun-24-22	Downgrade	Wells Fargo	Overweight → Equal Weight
Apr-04-22	Downgrade	Goldman	Neutral → Sell
Mar-02-22	Resumed	BofA Securities	Buy
Feb-18-22	Reiterated	KeyBanc Capital Markets	Overweight
Feb-18-22	Reiterated	Morgan Stanley	Overweight
Feb-18-22	Reiterated	Raymond James	Outperform
Feb-18-22	Reiterated	Stifel	Buy
Feb-18-22	Reiterated	UBS	Neutral
Feb-18-22	Reiterated	Wells Fargo	Overweight
Feb-11-22	Initiated	Goldman	Neutral
Jan-07-22	Resumed	Citigroup	Buy
Jan-07-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Sep-13-21	Upgrade	Cowen	Market Perform → Outperform
Sep-03-21	Upgrade	Barclays	Equal Weight → Overweight
May-25-21	Initiated	Barclays	Equal Weight
Jan-29-21	Downgrade	Piper Sandler	Overweight → Neutral
Jan-06-21	Downgrade	UBS	Buy → Neutral
Dec-15-20	Downgrade	Goldman	Buy → Neutral
Oct-01-20	Upgrade	Citigroup	Neutral → Buy
Sep-04-20	Downgrade	Argus	Buy → Hold
Jun-24-20	Initiated	Oppenheimer	Outperform
Mar-19-20	Upgrade	Stifel	Hold → Buy
Mar-18-20	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Mar-05-20	Initiated	Citigroup	Neutral
Feb-13-20	Initiated	Goldman	Buy
Jan-02-20	Upgrade	Evercore ISI	In-line → Outperform
Dec-17-19	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jun-26-19	Initiated	KeyBanc Capital Markets	Sector Weight
Apr-08-19	Downgrade	Evercore ISI	Outperform → In-line
Jan-02-19	Upgrade	Citigroup	Neutral → Buy
Jan-02-19	Upgrade	Morgan Stanley	Underweight → Overweight
Nov-02-18	Upgrade	Argus	Hold → Buy
Oct-16-18	Initiated	Barclays	Underweight
May-17-18	Resumed	Piper Jaffray	Overweight
Feb-06-18	Reiterated	Citigroup	Neutral
Jan-03-18	Initiated	Evercore ISI	Outperform
Jan-03-18	Upgrade	Raymond James	Mkt Perform → Outperform

View All

Baxter International Inc Stock (BAX) Latest News

Oct 26, 2026

Will Baxter's Q3 Earnings Show Progress Despite Cost Pressures? - Yahoo Finance

Oct 26, 2026

Will Baxter's Q3 Earnings Show Progress Despite Cost Pressures? - Zacks Investment Research

Oct 26, 2026

Oct 23, 2026

Baxter Says Novum Pump Issues Don't Show Securities Fraud - Law360

Oct 23, 2026

Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch

Oct 23, 2026

Baxter International Inc. Estimates – NYSE:BAX - TradingView

Oct 23, 2026

After Years Of Value Destruction, Baxter Remains Overvalued (NYSE:BAX) - Seeking Alpha

Oct 23, 2026